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SUMMARY 
 
Incidental pituitary adenoma is the common finding during brain imaging. According 
to multistep model of pituitary tumourigenesis genetic alterations provide the initiating event 
that transforms cells while hormones play a role in promoting cell proliferation. Development 
of pituitary adenoma in a case of excessive hypophysiotrophic hormones production or 
reduced feedback suppression by target gland hormones emphasizes the importance of 
hormonal stimulation in pituitary tumourigenesis. Pituitary hyperplasia has been reported in 
pregnancy, hypothyroidism and conditions such as CRH or GHRH hypersecretion. Moreover, 
recent study reported one case of gonadotroph macroadenoma and two cases of gonadtroph 
cells hyperplasia in patients with Klinefelter syndrome probably due to protracted stimulation 
of gonadotroph cells because of lack of androgen feedback. Significant changes of the 
hypothalamic-pituitary-gonadal axis occurred with aging. In females, after menopause, 
estradiol level decreases by 35-fold and estrone levels by 20-fold that results in increased 
gonadotropins levels. Similarly, FSH, but not LH, level is increased with advancing age in 
men, too, although the age-related difference in the level is less in comparison with women. 
Regarding these data, we hypothesised that high prevalence rate of pituitary incidentaloma in 
the elderly is associated with age-related decline in sex hormones levels and subsequent lack 
of feedback suppression leading to permanent gonadtrophs stimulation which is the crucial 
step in the pituitary tumour development. According to previously mentioned multistep model 
of pituitary tumourigenesis, incidentaloma will develop only in persons with already present 
intrinsic pituitary cell defects. However, further studies have to answer the questions of 
whether the incidence of pituitary tumours is more frequent in elderly, whether women with 
late onset menopause or those taking long-term hormone replacement therapy have lower rate 
of pituitary incidentaloma, and finally, is there any correlation between pituitary tumours 
incidence and serum concentrations of LH, FSH, bioavailable testosterone or estradiol.    
Incidental pituitary adenoma is the common finding during brain imaging by 
computed tomography or magnetic resonance. In meta-analysis of a large number of autopsy 
studies the prevalence of pituitary incidentalomas is reported to be 11,3% (1). However, little 
is known about pathogenetic mechanisms of pituitary adenoma developing. Several animal 
models stress the role of hormonal stimulation in the pathogenesis of these tumours which is 
not in agreement with another theory favouring the intrinsic pituitary cell defects in the 
developing of pituitary adenoma. An integrated approach to these two concepts results in 
multistep model of pituitary tumourigenesis in which genetic alterations provide the initiating 
event that transforms cells while hormones play a role in promoting cell proliferation (2). The 
evidence for the important role of hormonal stimulation is the development of pituitary 
adenoma in a case of excessive hypophysiotrophic hormones production or reduced feedback 
suppression by target gland hormones. Pituitary hyperplasia has been reported in pregnancy 
(3), hypothyroidism (4) and conditions such as CRH or GHRH hypersecretion (5, 6).  
Chanson et al. reported series of seven young women with incidentally discovered 
pituitary mass consistent with hyperplasia (7). Regarding the age of the patients, it could be 
related to gonadotroph cells involvement whose activity is supposed to be increased in 
peripubertal period. Recent study reported three cases of sellar mass in patients with 
Klinefelter syndrome, genetically determined disease characterised by primary gonadal defect 
(8). Gonadotroph macroadenoma has been found in one case and gonadtroph cells hyperplasia 
in other two. It tempts us to suggest that protracted stimulation of gonadotroph cells due to 
lack of androgen feedback might have been the most important factor in the formation of the 
pituitary masses in these patients. Conversely, in a small series of four patients with Turner 
syndrome no gonadotroph hyperplasia was present, but instead, corticotroph microadenomas 
were seen in three patients suggesting transdifferentiation of gonadotrophs to corticotrophs 
due to protracted stimulation of gonadotrophs or aberrant expression of gonadotropin-
releasing hormone (GnRH) receptors on corticotroph cells (9). In addition, antiandrogen 
administration in the male Sprague-Dawley rats produced a hypertrophia-hyperplasia of the 
follicle stimulating hormone (FSH) cells and hypertrophia of luteinizing hormone (LH) cells 
with marked alterations at the ultrastructural level suggestive of a hyperstimulation stage (10). 
 Significant changes of the hypothalamic-pituitary-gonadal axis occurred with aging in 
both, males and females. In females, after menopause, estradiol level decreases by 35-fold and 
estrone levels by 20-fold. The postmenopausal lack of estrogen results in increased 
gonadotropins levels and a decrease in the opioid inhibitory tone of GnRH secretion (11). In 
contrast to women, men do not experience a sharp decline in androgens level but rather slow 
decrease of gonadal function with age. However, only a minority of older men have elevated 
LH levels, while the majority have inappropriately normal LH due to pituitary defect (12). 
Conversely, FSH level is increased with advancing age in men, but the age-related difference 
in the level is less in comparison with women (13).    
 Regarding these data, we hypothesised that high prevalence rate of pituitary 
incidentaloma in the elderly is associated with age-related decline in sex hormones levels and 
subsequent lack of feedback suppression leading to permanent gonadotrophs stimulation 
which is the crucial step in the pituitary tumour development. It means that these 
incidentalomas are gonadotropinomas. According to previously mentioned multistep model of 
pituitary tumourigenesis, incidentaloma will develop only in persons with already present 
intrinsic pituitary cell defects. However, it would be expected to find a higher rate of pituitary 
tumours in women due to more abrupt rise of LH and FSH than in man. We believe that these 
tumours show a very little tendency for growth. Therefore, it could be of great interest to 
distinguish between these lesions from more aggressive pituitary tumours to avoid 
unnecessary frequent MRI surveillance and possible surgery.  
 Is developing of pituitary incidentaloma really associated with age-related decline of 
the sex hormones levels cannot be answered on the basis of so far published studies. 
Therefore further studies have to answer the questions of whether the incidence of pituitary 
tumours is more frequent in elderly, whether women with late onset menopause or those 
taking long-term hormone replacement therapy have lower rate of pituitary incidentaloma, 
and finally, is there any correlation between pituitary tumours incidence and serum 
concentrations of LH, FSH, bioavailable testosterone or estradiol.    
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